For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myelo
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eNTn9df
No comments:
Post a Comment